These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29971447)

  • 1. Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.
    Wang K; Ghasemi Falavarjani K; Nittala MG; Sagong M; Wykoff CC; van Hemert J; Ip M; Sadda SR
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3278-3285. PubMed ID: 29971447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study.
    Kwon S; Wykoff CC; Brown DM; van Hemert J; Fan W; Sadda SR
    Br J Ophthalmol; 2018 Aug; 102(8):1066-1071. PubMed ID: 29699979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.
    Fan W; Wang K; Ghasemi Falavarjani K; Sagong M; Uji A; Ip M; Wykoff CC; Brown DM; van Hemert J; Sadda SR
    Am J Ophthalmol; 2017 Aug; 180():110-116. PubMed ID: 28579062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema.
    Goel S; Kumar A; Ravani RD; Chandra P; Chandra M; Kumar V
    Indian J Ophthalmol; 2019 Jul; 67(7):1105-1108. PubMed ID: 31238421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion.
    Singer M; Tan CS; Bell D; Sadda SR
    Retina; 2014 Sep; 34(9):1736-42. PubMed ID: 24732695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.
    Ou WC; Brown DM; Payne JF; Wykoff CC
    Am J Ophthalmol; 2017 Aug; 180():8-17. PubMed ID: 28549848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
    Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial.
    Wykoff CC; Ou WC; Wang R; Brown DM; Cone C; Zamora D; Le RT; Sagong M; Wang K; Sadda SR;
    Ophthalmology; 2017 Jun; 124(6):919-921. PubMed ID: 28318636
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.
    Iesato Y; Imai A; Hirano T; Toriyama Y; Murata T
    Jpn J Ophthalmol; 2016 Mar; 60(2):86-94. PubMed ID: 26801502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome.
    Farinha C; Marques JP; Almeida E; Baltar A; Santos AR; Melo P; Costa M; Figueira J; Cachulo ML; Pires I; Silva R
    Ophthalmic Res; 2015; 55(1):10-8. PubMed ID: 26540281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.
    Fan W; Nittala MG; Fleming A; Robertson G; Uji A; Wykoff CC; Brown DM; van Hemert J; Ip M; Wang K; Falavarjani KG; Singer M; Sagong M; Sadda SR
    Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.
    Mimouni M; Segev O; Dori D; Geffen N; Flores V; Segal O
    Am J Ophthalmol; 2017 Oct; 182():160-167. PubMed ID: 28837790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
    Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.
    Tadayoni R; Waldstein SM; Boscia F; Gerding H; Gekkieva M; Barnes E; Das Gupta A; Wenzel A; Pearce I;
    Ophthalmology; 2017 Dec; 124(12):1778-1787. PubMed ID: 28807635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.
    Nishimura T; Machida S; Tada A; Oshida E; Muto T
    Doc Ophthalmol; 2019 Aug; 139(1):67-74. PubMed ID: 30980231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions.
    Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M
    Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
    Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
    Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
    BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.